 | Gra EX-25 | IC50 | 47.0 [1], 55.0 [2], 140.0 [3], 144.0 [4] |
| Gra EX-25 | Ki | 63.0 [1] |
 | CID 11570626 | IC50 | 6.6 [1], 15.7 [2], 20.0 [3], 80.0 [4] |
| CID 11570626 | Ki | 70.0 [1] |
 | 3-[[4-[1-[3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid | IC50 | 50.0 [1], 100.0 [2], 600.0 [3] |
 | 2-(4-Pyridinyl)-3-(4-fluorophenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 80.0 [1], 800.0 [2], 1402.81 [3] |
 | (+)-(1R)-1-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-propylpyridin-3-yl]ethanol | IC50 | 65.0 [1], 110.0 [2] |
 | 4-[[(4-Tert-butylcyclohexyl)-[[4-(trifluoromethoxy)phenyl]carbamoyl]amino]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 3.2 [1], 46.0 [2] |
 | 3-[[4-[[3-(3,5-Dichlorophenyl)-5-[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 44.0 [1], 84.0 [2], 86.2 [3], 113.8 [4] |
 | 4-[[(4-Tert-butylcyclohexyl)-(1-methylbenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 4.0 [1], 55.0 [2], 170.0 [3], 430.0 [4] |
 | 1-[(4-Tert-butylcyclohexyl)-[[4-(trifluoromethoxy)phenyl]carbamoyl]amino]-N-(2H-tetrazol-5-yl)-2,3-dihydro-1H-indene-5-carboxamide | IC50 | 1.01 [1], 2.31 [2], 15.0 [3], 18.0 [4] |
 | 5-Fluoro-2-[3-(1-hydroxyethyl)-5-pentyl-2,6-di(propan-2-yl)pyridin-4-yl]phenol | IC50 | 12.0 [1], 30.0 [2], 2200.0 [3], 8000.0 [4] |
 | 5-Fluoro-2-[3-(1-hydroxyethyl)-2,6-di(propan-2-yl)-5-propylpyridin-4-yl]phenol | IC50 | 10.0 [1], 18.0 [2], 1000.0 [3], 8000.0 [4] |
 | 2-[3-(1-Hydroxy-ethyl)-2,6-diisopropyl-5-propyl-pyridin-4-yl]-phenol | IC50 | 25.0 [1], 40.0 [2], 190.0 [3], 1100.0 [4] |
 | 2-[3-Ethyl-5-(1-hydroxyethyl)-2,6-di(propan-2-yl)pyridin-4-yl]-5-fluorophenol | IC50 | 16.0 [1], 20.0 [2], 2000.0 [3], 5000.0 [4] |
 | 4-[3-(5-Bromo-2-propoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrol-2-yl]pyridine | IC50 | 7.0 [1], 170.0 [2], 1442.12 [3] |
 | 3-Chloro-4-hydroxy-N-[(E)-(4-hydroxynaphthalen-1-yl)methylideneamino]benzamide | IC50 | 200.0 [1], 203.0 [2] |
 | 4-[4-(4-Fluorophenyl)-2-[4-(methylthio)phenyl]-1H-imidazol-5-yl]pyridine | IC50 | 117.22 [1], 490.0 [2] |
 | 4-[[9-Tert-butyl-2-oxo-3-[4-(trifluoromethoxy)phenyl]-1,3-diazaspiro[5.5]undecan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 32.0 [1], 34.0 [2], 92.0 [3] |
 | 2-[2,6-Diisopropyl-3-(hydroxymethyl)-5-pentyl-4-pyridyl]-5-fluorophenol | IC50 | 120.0 [1], 190.0 [2] |
 | 2,6-Diisopropyl-4-(4-fluorophenyl)-5-pentylpyridine-3-methanol | IC50 | 400.0 [1], 700.0 [2] |
 | 2-(4-Chlorophenyl)-4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 80.17 [1], 400.0 [2], 3200.0 [3] |
 | [4-(4-Fluoro-phenyl)-2,6-diisopropyl-5-(2-methyl-propenyl)-pyridin-3-yl]-methanol | IC50 | 2000.0 [1], 7000.0 [2] |
 | 4-[5-(4-Chloro-phenyl)-3-isopropyl-1H-pyrrol-2-yl]-pyridine | IC50 | 32.0 [1], 110.0 [2], 3032.0 [3] |
 | 2-(4-Chlorophenyl)-4-(2-phenoxyphenyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 6.5 [1], 150.31 [2], 290.0 [3] |
 | 2,4-Bis(4-chlorophenyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 23.01 [1], 190.0 [2], 2200.0 [3] |
 | 3-[[1-[(4-Tert-butylcyclohexyl)-[[4-(trifluoromethoxy)phenyl]carbamoyl]amino]-2,3-dihydro-1H-indene-5-carbonyl]amino]propanoic acid | IC50 | 3.8 [1], 489.0 [2], 1085.0 [3] |
 | 2-(4-Pyridinyl)-3-(4-fluorophenyl)-5-(3-chlorophenyl)-1H-pyrrole | IC50 | 40.0 [1], 420.73 [2], 990.0 [3] |
 | 2-(4-Pyridinyl)-3-(4-fluorophenyl)-5-(2,4-dichlorophenyl)-1H-pyrrole | IC50 | 40.0 [1], 420.73 [2], 950.0 [3] |
 | 2-(4-Pyridinyl)-3-(3-bromophenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 80.17 [1], 150.0 [2], 1700.0 [3] |
 | 2-(4-Pyridinyl)-3-[2-(allyloxy)phenyl]-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 17.0 [1], 260.0 [2], 4742.42 [3] |
 | 2-(4-Chlorophenyl)-4-(4-biphenylyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 140.0 [1], 3303.7 [2], 3800.0 [3] |
 | 2-(4-Chlorophenyl)-4-(4-iodophenyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 130.0 [1], 140.28 [2], 750.0 [3] |
 | 2-(4-Chlorophenyl)-4-(4-phenoxyphenyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 27.0 [1], 110.0 [2], 250.03 [3] |
 | 4-[2-(4-Chlorophenyl)-4-(3-phenoxyphenyl)-1H-imidazol-5-yl]pyridine | IC50 | 13.0 [1], 150.0 [2], 220.29 [3] |
 | 2-(4-Chlorophenyl)-4-(3-biphenylyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 61.0 [1], 590.2 [2], 3000.0 [3] |
 | 4-[2-(4-Chloro-phenyl)-5-(2,4-dipropoxy-phenyl)-3H-imidazol-4-yl]-pyridine | IC50 | 13.0 [1], 120.0 [2], 2404.36 [3] |
 | 4-[5-Cyclohexyl-3-(4-fluoro-phenyl)-1H-pyrrol-2-yl]-pyridine | IC50 | 90.0 [1], 180.3 [2], 490.0 [3] |
 | 4-[3-(4-Fluoro-phenyl)-1H-pyrrol-2-yl]-pyridine | IC50 | 160.32 [1], 3000.0 [2] |
 | 2-(4-Pyridinyl)-3,5-bis(4-fluorophenyl)-1H-pyrrole | IC50 | 90.0 [1], 340.41 [2], 350.0 [3] |
 | 2-(4-Pyridinyl)-3-(2-ethoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 40.0 [1], 500.0 [2], 14223.29 [3] |
 | 2-(4-Pyridinyl)-3-(2-methoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 70.0 [1], 500.0 [2], 2654.61 [3] |
 | 2-(4-Pyridinyl)-3-(2-propoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 8.0 [1], 140.0 [2], 2844.46 [3] |
 | 2-(4-Pyridinyl)-3-(2-bromophenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 26.0 [1], 1000.0 [2], 2300.0 [3] |
 | 2-(4-Pyridinyl)-3-(4-bromophenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 140.0 [1], 300.61 [2], 2300.0 [3] |
 | 2-(4-Pyridinyl)-3-(4-methoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 100.0 [1], 1150.8 [2], 1600.0 [3] |
 | 4-[3-(4-Fluoro-phenyl)-5-p-tolyl-1H-pyrrol-2-yl]-pyridine | IC50 | 250.0 [1], 1690.44 [2], 2200.0 [3] |
 | 2-(4-Pyridinyl)-3-phenyl-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 60.0 [1], 210.38 [2], 380.0 [3] |
 | 2-(4-Pyridinyl)-3-(3-methoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 60.0 [1], 420.73 [2], 450.0 [3] |
 | 4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-pyrrole-2-yl]benzonitrile | IC50 | 50.0 [1], 140.0 [2], 4900.0 [3] |
 | 2-(4-Pyridinyl)-3-(2-isobutoxyphenyl)-5-(4-chlorophenyl)-1H-pyrrole | IC50 | 3.0 [1], 200.0 [2], 3767.04 [3] |
 | 3-[[5-[2-[[3-Chloro-4-[2-methyl-4-(trifluoromethyl)phenyl]anilino]methyl]-5-(trifluoromethyl)phenyl]pyridine-2-carbonyl]amino]propanoic acid | IC50 | 22.0 [1] |
| 3-[[5-[2-[[3-Chloro-4-[2-methyl-4-(trifluoromethyl)phenyl]anilino]methyl]-5-(trifluoromethyl)phenyl]pyridine-2-carbonyl]amino]propanoic acid | Ki | 17.0 [1], 17.2 [2] |
 | 2-(4-Pyridinyl)-3,5-bis(4-chlorophenyl)-1H-pyrrole | IC50 | 160.32 [1], 190.0 [2], 810.0 [3] |
 | SB-203580 analogue (4) | IC50 | 160.03 [1], 270.0 [2], 2900.0 [3] |
 | Glucagon Receptor Antagonist I | IC50 | 129.0 [1], 181.0 [2] |
 | (2R)-3-[[4-[[4-(Cyclohexen-1-yl)-N-[(3,5-dichlorophenyl)carbamoyl]anilino]methyl]benzoyl]amino]-2-hydroxypropanoic acid | IC50 | 3.9 [1] |
| (2R)-3-[[4-[[4-(Cyclohexen-1-yl)-N-[(3,5-dichlorophenyl)carbamoyl]anilino]methyl]benzoyl]amino]-2-hydroxypropanoic acid | Ki | 85.0 [1] |
 | 3-Chloro-4-hydroxy-N-[(E)-[1-[(4-propan-2-ylphenyl)methyl]indol-4-yl]methylideneamino]benzamide | IC50 | 23.0 [1], 84.0 [2] |
 | 3-Cyano-4-hydroxy-N-[(E)-[1-[(2,3,5,6-tetramethylphenyl)methyl]indol-4-yl]methylideneamino]benzamide | IC50 | 2.3 [1] |
 | 3-Cyano-N-[(E)-[3,5-dimethoxy-4-[(4-propan-2-ylphenyl)methoxy]phenyl]methylideneamino]-4-hydroxybenzamide | IC50 | 20.0 [1] |
 | 3-(4-((1-(4-Cyclohexenylphenyl)-3-(3,5-dichlorophenyl)ureido)methyl)benzamido)propanoic acid | IC50 | 12.0 [1], 27.0 [2] |
 | 2,4-Bis(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 100.0 [1], 2000.0 [2] |
 | 3-Chloro-N-[(E)-[4-[2-(diethylamino)-2-oxoethoxy]naphthalen-1-yl]methylideneamino]-4-hydroxybenzamide | IC50 | 49.7 [1], 130.0 [2] |
 | 4-[[5,6-Dichloro-3-methyl-2-[4-(trifluoromethoxy)phenyl]iminobenzimidazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 4.0 [1], 23.0 [2] |
 | 3-[[4-[[[3,5-Bis(trifluoromethyl)phenyl]carbamoyl-(4-tert-butylcyclohexyl)amino]methyl]benzoyl]amino]propanoic acid | IC50 | 16.0 [1], 56.0 [2] |
 | 3-{4-[1-(4-Tert-butylphenyl)-3-(4-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid | IC50 | 36.0 [1], 96.0 [2] |
 | 2,6-Diisopropyl-4-phenyl-5-pentylpyridine-3-methanol | IC50 | 1400.0 [1] |
 | 3-Chloro-4-hydroxy-N-[(E)-[4-[(4-propan-2-ylphenyl)methoxy]naphthalen-1-yl]methylideneamino]benzamide | IC50 | 4.3 [1], 53.0 [2] |
 | 4-[4-(4-Fluorophenyl)-5-(4-pyridinyl)-1H-pyrrole-2-yl]benzoic acid | IC50 | 90.16 [1], 3000.0 [2] |
 | 2-Phenyl-4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 130.02 [1], 20000.0 [2] |
 | 4-[[8-Tert-butyl-3-(3,5-dichlorophenyl)-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 36.0 [1], 116.0 [2] |
 | 3-[[4-[[8-Tert-butyl-3-(3,5-dichlorophenyl)-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 43.0 [1], 423.0 [2] |
 | 3-[[4-[[5-(3,5-Dichlorophenyl)-3-[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 95.0 [1], 230.0 [2] |
 | 3-[[4-[(4-Chloro-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]anilino)methyl]benzoyl]amino]propanoic acid | IC50 | 53.0 [1], 76.0 [2] |
 | 3-[[4-[[8-Tert-butyl-2-oxo-3-[4-(trifluoromethoxy)phenyl]-1,3-diazaspiro[4.5]decan-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 336.0 [1], 459.0 [2] |
 | 4-[[8-Tert-butyl-3-(3-chlorophenyl)-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 94.0 [1], 353.0 [2] |
 | 4-[[5-(3,5-Dichlorophenyl)-3-[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 35.0 [1], 36.0 [2] |
 | 3-[[4-[(4-Chloro-N-[4-[4-(trifluoromethoxy)phenyl]-1,3-thiazol-2-yl]anilino)methyl]benzoyl]amino]propanoic acid | IC50 | 53.0 [1], 82.0 [2] |
 | 2-(4-Isopropylphenyl)-4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 280.54 [1], 700.0 [2] |
 | 2-(4-((3,5-Bis(4-(trifluoromethoxy)phenyl)-1H-pyrazol-1-yl)methyl)benzamido)acetic acid | IC50 | 560.0 [1], 3000.0 [2] |
 | 4-[1-[3,5-Bis[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]ethyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 130.0 [1], 1300.0 [2] |
 | 3-[[4-[[9-Tert-butyl-2-oxo-3-[4-(trifluoromethoxy)phenyl]-1,3-diazaspiro[5.5]undecan-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 182.0 [1], 282.0 [2] |
 | 2-[4-(Methoxycarbonyl)phenyl]-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole | IC50 | 300.61 [1], 8700.0 [2] |
 | 2-(4-Methoxyphenyl)-5-(4-fluorophenyl)-4-(4-pyridyl)-1H-imidazole | IC50 | 100.0 [1], 13000.0 [2] |
 | 4-[5-(4-Fluoro-phenyl)-2-p-tolyl-3H-imidazol-4-yl]-pyridine | IC50 | 90.16 [1], 1300.0 [2] |
 | 3-[[4-[[8-Tert-butyl-2-oxo-3-[3-(trifluoromethoxy)phenyl]-1,3-diazaspiro[4.5]decan-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 60.0 [1], 515.0 [2] |
 | 3-[[4-[[[4-(3,4-Dichlorophenyl)-1,3-thiazol-2-yl]-(5,6,7,8-tetrahydronaphthalen-2-yl)amino]methyl]benzoyl]amino]propanoic acid | IC50 | 54.0 [1], 79.0 [2] |
 | 2-(3-Bromophenyl)-4-(4-fluorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 150.31 [1], 1400.0 [2] |
 | 4-[[5-Cyclohexyl-3-[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 120.0 [1], 160.0 [2] |
 | 4-[[3,5-Bis[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 43.0 [1], 47.0 [2] |
 | 4-[[8-Tert-butyl-3-(4-chlorophenyl)-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 116.0 [1], 446.0 [2] |
 | 2-(4-Chlorophenyl)-4-(2-butoxyphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 8.5 [1], 110.0 [2] |
 | 3-[[4-[[8-Tert-butyl-3-(3-chlorophenyl)-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]benzoyl]amino]propanoic acid | IC50 | 351.0 [1], 601.0 [2] |
 | 4-[[8-Tert-butyl-2-oxo-3-[4-(trifluoromethoxy)phenyl]-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 105.0 [1], 193.0 [2] |
 | N-[3-Cyano-4-methyl-5-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]thiophen-2-yl]-2-ethylbutanamide | IC50 | 185.0 [1], 368.0 [2] |
 | 3-[[4-[[4-(Trifluoromethoxy)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]anilino]methyl]benzoyl]amino]propanoic acid | IC50 | 51.0 [1], 92.0 [2] |
 | N-[3-Cyano-6-[(2,4-dichlorophenyl)methyl-propan-2-ylamino]-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-2-ethylbutanamide | IC50 | 59.0 [1], 129.0 [2] |
 | 4-[[3-(3,5-Dichlorophenyl)-5-[4-(trifluoromethoxy)phenyl]pyrazol-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 39.0 [1], 330.0 [2] |
 | 4-[[3-[1-(4-Bromophenyl)ethyl]-8-tert-butyl-2-oxo-1,3-diazaspiro[4.5]decan-1-yl]methyl]-N-(2H-tetrazol-5-yl)benzamide | IC50 | 30.0 [1], 164.0 [2] |
Calculator
